Omar Dabas
No ORCID on file
· 1 paper in corpus
article
2025
This prospective, open-label, two-arm clinical study evaluated the efficacy and safety of prolonged gonadotropin-releasing hormone agonist (GnRH-a) therapy exceeding 24 months, combined with norethisterone acetate (NETA) add-back, in women …